Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €11.33 EUR
Change Today -0.143 / -1.25%
Volume 0.0
XYXR On Other Exchanges
Symbol
Exchange
Frankfurt
As of 3:43 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Julie Anne Smith

Chief Executive Officer, President and Director,Raptor Pharmaceuticals Corp.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 3 different industries.

See Board Relationships
44$2,458,008
As of Fiscal Year 2014

Background*

Ms. Julie Anne Smith has been the Chief Executive Officer and President of Raptor Pharmaceuticals Corp. since January 1, 2015. Ms. Smith served as the Chief Operating Officer and Executive Vice President of Strategy at Raptor Pharmaceuticals Corp. since September 10, 2012. Ms. Smith served as the Chief Commercial Officer and Vice President of Alexion Montréal Corp. (Formerly, Enobia Pharma, Inc.) since September 22, 2008. Ms. Smith served as Vice President of Marketing ...

Read Full Background

Corporate Headquarters*

7 Hamilton Landing
Novato, California 94949

United States

Phone: 415-408-6200
Fax: 415-382-8002

Board Members Memberships*

2015-Present
Chief Executive Officer, President and Director

Education*

BS
Cornell University

Other Affiliations*

Annual Compensation*

Salary$421,087
Total Annual Compensation$421,087

Stock Options*

All Other Compensation$52,326
Exercised Options37,950
Exercisable Options91,228
Unexercisable Options342,887
Total Number of Options472,065

Total Compensation*

Total Annual Cash Compensation$627,668
Total Short Term Compensation$421,087
Other Long Term Compensation$52,326
Total Calculated Compensation$2,458,008
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XYXR:GR €11.33 EUR -0.143

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jay T. Flatley Chief Executive Officer and Director
Illumina Inc.
$859.2K
Michael R. McMullen Chief Executive Officer, President, Director and Member of Executive Committee
Agilent Technologies Inc.
$606.3K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RAPTOR PHARMACEUTICAL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.